Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216


The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma.

Masserini B, Morelli V, Bergamaschi S, Ermetici F, Eller-Vainicher C, Barbieri AM, Maffini MA, Scillitani A, Ambrosi B, Beck-Peccoz P, Chiodini I.

Eur J Endocrinol. 2009 Jan;160(1):87-92. doi: 10.1530/EJE-08-0485. Epub 2008 Oct 3.


The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.

Palmieri S, Morelli V, Polledri E, Fustinoni S, Mercadante R, Olgiati L, Eller Vainicher C, Cairoli E, Zhukouskaya VV, Beck-Peccoz P, Chiodini I.

Eur J Endocrinol. 2013 Feb 15;168(3):289-96. doi: 10.1530/EJE-12-0803. Print 2013 Mar.


Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.

Valli N, Catargi B, Ronci N, Vergnot V, Leccia F, Ferriere JM, Chene G, Grenier N, Laurent F, Tabarin A.

Eur J Endocrinol. 2001 Apr;144(4):401-8.


Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.

Mantero F, Masini AM, Opocher G, Giovagnetti M, Arnaldi G.

Horm Res. 1997;47(4-6):284-9.


Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?

Eller-Vainicher C, Morelli V, Salcuni AS, Torlontano M, Coletti F, Iorio L, Cuttitta A, Ambrosio A, Vicentini L, Carnevale V, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A, Chiodini I.

Eur J Endocrinol. 2010 Jan;162(1):91-9. doi: 10.1530/EJE-09-0775. Epub 2009 Oct 1.


Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden.

Olsen H, Nordenström E, Bergenfelz A, Nyman U, Valdemarsson S, Palmqvist E.

Endocrine. 2012 Aug;42(1):164-73. doi: 10.1007/s12020-012-9622-2. Epub 2012 Feb 17.


Late-night and low-dose dexamethasone-suppressed cortisol in saliva and serum for the diagnosis of cortisol-secreting adrenal adenomas.

Deutschbein T, Unger N, Hinrichs J, Walz MK, Mann K, Petersenn S.

Eur J Endocrinol. 2009 Nov;161(5):747-53. doi: 10.1530/EJE-09-0517. Epub 2009 Sep 2.


Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism.

Eller-Vainicher C, Morelli V, Ulivieri FM, Palmieri S, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Scillitani A, Beck-Peccoz P, Chiodini I.

J Bone Miner Res. 2012 Oct;27(10):2223-30. doi: 10.1002/jbmr.1648.


Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures.

Chiodini I, Viti R, Coletti F, Guglielmi G, Battista C, Ermetici F, Morelli V, Salcuni A, Carnevale V, Urbano F, Muscarella S, Ambrosi B, Arosio M, Beck-Peccoz P, Scillitani A.

Clin Endocrinol (Oxf). 2009 Feb;70(2):208-13. doi: 10.1111/j.1365-2265.2008.03310.x. Epub 2008 Jun 10.


Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.

Chiodini I, Morelli V, Salcuni AS, Eller-Vainicher C, Torlontano M, Coletti F, Iorio L, Cuttitta A, Ambrosio A, Vicentini L, Pellegrini F, Copetti M, Beck-Peccoz P, Arosio M, Ambrosi B, Trischitta V, Scillitani A.

J Clin Endocrinol Metab. 2010 Jun;95(6):2736-45. doi: 10.1210/jc.2009-2387. Epub 2010 Apr 7.


Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients.

Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, Epaminonda P, Augello G, Enrini R, Ambrosi B, Adda G, Trischitta V.

Eur J Endocrinol. 2005 Dec;153(6):837-44.


Role of adrenal gland scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass.

Donadio F, Morelli V, Salcuni AS, Eller-Vainicher C, Carletto M, Castellani M, Dellavedova L, Scillitani A, Beck-Peccoz P, Chiodini I.

J Endocrinol Invest. 2009 Jul;32(7):576-80. doi: 10.3275/6360. Epub 2009 Jun 15.


Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol.

Putignano P, Dubini A, Toja P, Invitti C, Bonfanti S, Redaelli G, Zappulli D, Cavagnini F.

Eur J Endocrinol. 2001 Aug;145(2):165-71.


[Bone mineral density and biological markers of bone repair in patients with adrenal incidentaloma: effect of subclinical hypercortisolism].

Bardet S, Rohmer V, Boux de Casson F, Coffin C, Ronci N, Sabatier JP, Lecomte P, Audran M, Henry-Amar M, Tabarin A.

Rev Med Interne. 2002 Jun;23(6):508-17. French.


Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods.

Beko G, Varga I, Glaz E, Sereg M, Feldman K, Toth M, Racz K, Patocs A.

Clin Chim Acta. 2010 Mar;411(5-6):364-7. doi: 10.1016/j.cca.2009.11.033. Epub 2009 Dec 5.


Late-night salivary cortisol as a screening test for the diagnosis of Cushing's syndrome in Japan.

Doi M, Sekizawa N, Tani Y, Tsuchiya K, Kouyama R, Tateno T, Izumiyama H, Yoshimoto T, Hirata Y.

Endocr J. 2008 Mar;55(1):121-6. Epub 2008 Jan 17.


Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.

Reimondo G, Allasino B, Bovio S, Saba L, Ardito A, Angeli A, Terzolo M.

J Endocrinol Invest. 2011 Jan;34(1):e1-5. doi: 10.3275/7167. Epub 2010 Jul 13.


Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency.

Ceccato F, Barbot M, Zilio M, Ferasin S, Occhi G, Daniele A, Mazzocut S, Iacobone M, Betterle C, Mantero F, Scaroni C.

Eur J Endocrinol. 2013 Jun 1;169(1):31-6. doi: 10.1530/EJE-13-0159. Print 2013 Jul.

Items per page

Supplemental Content

Write to the Help Desk